Disclosure Of Interests In Other Entities [Text Block]

Rhön-Klinikum AG - Filing #6464263

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2024-12-31
2023-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of interests in other entities [text block]
8
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
1,856 EUR
1,455 EUR
Non-controlling interests
30,042 EUR
28,186 EUR
Current assets
904,110 EUR
789,211 EUR
Non-current assets
952,371 EUR
981,313 EUR
Current liabilities
404,853 EUR
335,473 EUR
Non-current liabilities
125,656 EUR
154,825 EUR
Revenue
1.595.619 EUR
1.463.979 EUR
Profit (loss)
1,856 EUR
45,207 EUR
EUR
EUR
43,351 EUR
EUR
43,351 EUR
EUR
40,167 EUR
EUR
38,712 EUR
EUR
1,455 EUR
38,712 EUR
Comprehensive income
45,746 EUR
39,733 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
6
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
EUR
539,000 EUR
EUR
EUR
539,000 EUR
EUR
539,000 EUR
EUR
434,000 EUR
EUR
434,000 EUR
EUR
EUR
434,000 EUR
Investments accounted for using equity method
643,000 EUR
533,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
6.4.2
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
279,864 EUR
206,042 EUR
Other current financial liabilities
10,981 EUR
11,514 EUR
Other non-current financial liabilities
4,939 EUR
7,213 EUR
Tax expense (income)
10,997 EUR
7,562 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.